CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Phone+1-800-6848880
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) announced its quarterly earnings results on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share for the quarter, beating analysts' consensus estimates of $0.79 by $0.20. The healthcare company earned $1.07 billion during the quarter, compared to analyst estimates of $1.01 billion. The business's revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.54 earnings per share. View CareFusion's Earnings History.
Has CareFusion been receiving favorable news coverage?
Media coverage about CFN stock has trended somewhat positive on Tuesday, InfoTrie reports. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. CareFusion earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news headlines about the healthcare company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term.
What other stocks do shareholders of CareFusion own?
What is CareFusion's official website?
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (NYSE CFN)
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
